European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 1.07% to 1,749.50 on the S&P Europe Select ADR Index, which has tumbled 7.3% for the week so far.
From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and semiconductor company Sequans Communications (SQNS), which climbed 13% and 2.4% respectively. They were followed by pharmaceutical company Sanofi (SNY) and consumer goods company Unilever (UL), which increased 1.8% and 1.6% respectively.
The decliners from continental Europe were led by telecommunications operator Nokia (NOK) and accommodations booking site trivago (TRVG), which fell 4.1% and 3.1% respectively. They were followed by internet browser company Opera (OPRA) and 3D printer company Materialise (MTLS), which decreased 1.7% and 1.3% respectively.
The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which advanced 10.3% and 8.6% respectively. They were followed by pharmaceutical company GSK (GSK) and educational publisher Pearson (PSO), which were up 1.8% and 1.7% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.9% and 1.8% respectively. They were followed by lender HSBC (HSBC) and biopharmaceutical company Amarin (AMRN), which were down 1.5% and 1.4% respectively.
Comments